Back
UiPath Vs. Nukkleus Industry Stock Comparison
Sell
35
PATH
UiPath
Last Price:
$12.74
Seasonality Move:
-1.3%
Buy
59
NUKK
Nukkleus
Last Price:
$53.50
Seasonality Move:
-21.57%
Sell
35
UiPath (PATH)
is a Sell
Is UiPath a Buy, Sell or Hold?
-
PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUKK Stock Price Chart
PATH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 39.9 | Sell |
Chaikin Money Flow: | -8612667 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.13 - 14.83) | Sell |
Bollinger Bands (100): | (11.8 - 13.72) | Buy |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.39 | Buy |
Relative Strength Index (14 RSI): | 98.34 | Buy |
Chaikin Money Flow: | 16674276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-5.69 - 13.77) | Buy |
Bollinger Bands (100): | (-2.17 - 7.69) | Buy |
PATH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.25 | Sell |
20-day SMA: | 14.29 | Sell |
50-day SMA: | 13.36 | Sell |
200-day SMA: | 15.11 | Sell |
8-day EMA: | 13.99 | Sell |
20-day EMA: | 14.05 | Sell |
50-day EMA: | 13.58 | Sell |
200-day EMA: | 14.72 | Sell |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.93 | Buy |
20-day SMA: | 4.57 | Buy |
50-day SMA: | 3.23 | Buy |
200-day SMA: | 4.39 | Buy |
8-day EMA: | 14.22 | Buy |
20-day EMA: | 7.21 | Buy |
50-day EMA: | 4.26 | Buy |
200-day EMA: | 11.08 | Buy |
UiPath Earnings Growth & PATH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.41 per share, and a decrease next year of $0.00 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
UiPath Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |